Joseph Woolery
About Joseph Woolery
Joe Woolery, Vice President Early-Stage Development Americas
Joe Woolery serves as the Vice President of Early-Stage Development for the Americas. In this role, he oversees the development and implementation of early-stage clinical trials and strategies. He brings extensive experience in oncology pharmacy and clinical research to this position.
Joseph Woolery Education and Qualifications
Joe Woolery holds a Doctor of Pharmacy (PharmD) degree from the University of Missouri-Kansas City. He further specialized in clinical pharmacy practice by completing a residency at The University of Arizona. Additionally, he completed an oncology fellowship at H. Lee Moffitt Cancer Center and Research Institute, emphasizing his dedication to oncology practice and research.
Joe Woolery Board Certified Oncology Pharmacist
Joe Woolery is a board certified oncology pharmacist, highlighting his proficiency and expertise in oncology pharmacotherapy. This certification underscores his specialized knowledge in managing medications for cancer patients and delivering optimal therapeutic outcomes.
Joe Woolery Memberships in Professional Organizations
Joe Woolery is a member of both the American Society of Clinical Oncology and the European Society of Medical Oncology. These memberships connect him to a network of professionals dedicated to cancer treatment and research, allowing him to stay updated on the latest developments and best practices in oncology.
Joe Woolery's Professional Background and Experience
Previously, Joe Woolery held pivotal positions at Seagen, where he worked on registrational studies for Adcetris in Peripheral T-Cell Lymphoma and Tukysa in HER2+ Metastatic Breast Cancer. His earlier career also includes practicing as a Clinical Oncology Pharmacist at the University of Texas M.D. Anderson Cancer Center and Banner M.D. Anderson Cancer Centers.